Executives from biotech company Emergent BioSolutions were grilled by lawmakers Wednesday over multiple failures in their manufacturing of coronavirus vaccines, which led the company to throw out 15 million doses earlier this year due to contamination. This is New York Congressmember Carolyn Maloney speaking at the hearing Wednesday.
Rep. Carolyn Maloney: “This is unfair to the American taxpayer, to say the very least. When you have a contract, you should produce the product. So far, we haven’t even gotten one dose of the product out to the American taxpayer, yet you have been able to get bonuses, millions of dollars in pay going out to executives, and they have not completed the contract.”
Former government officials serve on the board of Emergent, and the company spends an average of $3 million a year on lobbying lawmakers.